 |
| Targeted Drug Delivery Market |
The Global Targeted Drug Delivery Market Is Estimated To Be Valued At US$ 761.95 Mn In 2023 And Is Expected
To Exhibit A CAGR Of 15% Over The
Forecast Period 2023 To 2030, As Highlighted In A New Report Published By Coherent
Market Insights.
Market Overview:
Targeted Drug Delivery Involves The Delivery Of Therapeutic Drugs Directly To
Disease Sites In The Body Through Various Routes Of Administration Like Oral,
Injectable, Inhalation Etc. Without Affecting Healthy Cells And Tissues. This Reduces
Toxicity And Enhances The Bioavailability And Efficacy Of Drugs. Targeted Drug
Delivery Helps Reduce Side Effects And Improves Patient Compliance. Some Targeted
Delivery Technologies Include Liposomes, Nanoparticles, Magnetic Drug
Targeting, Ligand-Receptor-Based Targeting And Controlled Release Technology.
Market Key Trends:
One Of The Key Trends In The Targeted Drug Delivery Market Is The Increasing
Focus On Development Of Nanoparticles-Based Drug Delivery Systems. Nanoparticle
Carriers Have The Ability To Encapsulate Drug Molecules And Carry Them To The
Target Site In The Body In A Controlled And Sustained Manner. Companies Are
Developing Novel Nanoparticles Like Polymeric Nanoparticles, Dendrimers,
Nanotubes And Inorganic Nanoparticles For Targeted Delivery Of Various Drugs To
Treat Cancer, Neurological Disorders And Infectious Diseases. For Instance,
Abbvie Inc Is Developing Tanezumab, An Experimental Treatment For
Osteoarthritis Using Nanoparticle Technology To Deliver The Treatment Directly
To Joints.
Porter’s Analysis
Threat Of New Entrants: The Threat Is Moderate As The Targeted
Drug Delivery Market Requires High R&D Investments And Regulatory
Approvals Which Create Entry Barriers For New Players.
Bargaining Power Of Buyers: The Bargaining Power Of Buyers Is Moderate As The
Targeted Drugs Offered By Pharmaceutical Companies Address Specific Medical
Conditions And Diseases.
Bargaining Power Of Suppliers: The Bargaining Power Of Suppliers Is Low As
Major Pharmaceutical Companies Have Established Partnerships With Few Material
Suppliers And Manufacturing Players.
Threat Of New Substitutes: The Threat Is Low As Targeted Drug Delivery Offers
Advanced Drug Administration With More Precision And Improved Bioavailability
Compared To Conventional Drug Formulations.
Competitive Rivalry: The Competitive Rivalry In The Targeted Drug Delivery
Market Is High Due To The Presence Of Major Players.
Key Takeaways
The Global Targeted Drug Delivery Market Is Expected To Witness High Growth,
Exhibiting CAGR Of 15.% Over The Forecast Period, Due To Increasing Prevalence
Of Chronic Diseases And Rising Demand For Targeted Therapies.
Regional Analysis: North America Dominated The Global Targeted Drug Delivery
Market In 2023 And Is Expected To Continue Its Dominance Over The Forecast
Period Due To Growing R&D Investments And Presence Of Major Players In The
Region. However, Asia Pacific Is Anticipated To Witness Fastest Growth Rate
Over The Forecast Period Owing To Increasing Healthcare Expenditures And Large
Patient Pool In China And India.
Key Players Analysis: Key Players Operating In The Targeted Drug Delivery
Market Are Abbvie Inc., Ablynx NV By Sanofi SA, Arrowhead Pharmaceuticals, Inc.,
Baxter International Inc., Astrazeneca PLC, Boston Scientific Corporation, Becton,
Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye
Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals
Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan
Liposome Company, Ltd., And 3M Company. These Key Players Are Focusing On New
Product Launches And Strategic Collaborations For Market Expansion.